📢 Join the 6th EFMC² Tandem Talk!
Maria Méndez Pérez and Hans Matter from Sanofi will discuss Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitors.
Free and open to all, thanks to Schrödinger.
📆 October 9 | 16:00-17:00 CET
🔗
buff.ly/L3NXc0E